NCT01082367 - Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients

Interventions

DRUG

TOBI

TOBI (tobramycin inhaled solution)

DRUG

Placebo

Trial Locations (19)

4032

Novartis Investigative Site, Debrecen

4043

Novartis Investigative Site, Debrecen

6725

Novartis Investigative Site, Szeged

7400

Novartis Investigative Site, Kaposvár

8032

Novartis Investigative Site, Zurich

20122

Novartis Investigative Site, Milan

20395

Novartis Investigative Site, Bucharest

21131

Novartis Investigative Site, Alexandria

33076

Novartis Investigative Site, Bordeaux

75019

Novartis Investigative Site, Paris

150003

Novartis Investigative Site, Yaroslavl

394036

Novartis Investigative Site, Voronezh

420012

Novartis Investigative Site, Kazan'

M5G 1X8

Novartis Investigative Site, Toronto

H3T1C5

Novartis Investigative Site, Montreal

01307

Novartis Investigative Site, Dresden

265 00

Novartis Investigative Site, Pátrai

546 29

Novartis Investigative Site, Thessaloniki

546 42

Novartis Investigative Site, Thessaloniki